Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple Sclerosis
April 01, 2015 at 08:07 AM EDT
Receptos, Inc. (Nasdaq: RCPT) announced today that the Company has completed enrollment in the RADIANCE Phase 3 trial of ozanimod ...